Predictable factors for intervention with heparin free plasmapheresis in impending liver cell failure due to consumption of phosphorus rodenticide
DOI:
https://doi.org/10.18203/2320-6012.ijrms20193390Keywords:
Yellow Phosphorus paste, Zinc phosphide powder, Plasmapheresis, Liver cell failure, Rodenticide, L-ornithine-L- aspartate.Abstract
Background: Yellow phosphorus containing rodenticide poisoning are common in Adult critical care. They cause coagulopathy and liver cell failure in humans. Till date, only liver transplants had been advocated as the final treatment of fulminant liver failure occurring as a complication of rodenticide poisoning. In this study, an innovative Treatment approach was given to liver cell failure cases who had consumed yellow phosphorus paste.
Methods: Retrospective analysis of case records of liver cell failure cases due to the consumption of phosphorus containing Rodenticide poisonings, were analysed for a period of 1 year from January 2018 to January 2019 in a public hospital. Medical case records were obtained from records department and Postmortem registers. Symptoms, signs, investigations, treatments, complications, and outcomes were tabulated.
Results: Total 11 cases were studied. 8 cases of liver cell failure and coagulopathy in whom therapeutic heparin free plasmapheresis was given, recovered completely from liver cell failure. A significant drop in Haemoglobin, platelet count, PT INR Ratio and rise in serum alkaline phosphatase, were the predictable factors used for the intervention of therapy with 5 cycles of heparin free plasmapheresis to eliminate toxic effects of phosphorus on liver cells and in the blood. A comparative analysis of untreated cases (n=3) vs treated with plasmapheresis (n=8), showed a significant statistical difference (P <0.005) in outcomes with a degree of freedom=2.
Conclusions: Plasmapheresis can be a therapeutic treatment for liver cell failure caused due to the consumption of yellow phosphorus. Predictable factors for impending liver cell failure in whom plasmapheresis will be of benefit are dependent upon prothrombin time, INR ratio, Liver enzymes and time interval between consumption and onset of liver cell failure.
References
Anupama Mauskar, Kunal Mehta , Leena Nagotkar, and Preeti Shanbag. Acute hepatic failure due to yellow phosphorus ingestions| August 2019 | Vol 7 | Issue 8 Page 6 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113395 [pubmed]
Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW. Critical Care Toxicology-Diagnosis and Management of the Critically Poisoned Patient. PA: Elsevier; 2005: 851-861.
Fernandez OU, Canizares LL. Acute hepatotoxicity from ingestion of yellow phosphorus-containing fireworks. J Clin Gastroenterol. 1995;21(2):139-42.
Chikkaveeraiah SK, Marijayanth M, Reddy PK, Kaluvakuri S. Clinical profile and outcome of rodenticide poisoning in patients admitted to a tertiary care teaching hospital in Mysore, Karnataka, India. Int J Res Med Sci. 2016;4(11):5023-7.
Bone Spine. Phosphorus Metabolism. Available at: https://boneandspine.com/phosphorus-metabolism/.
Razzaque MS. Phosphate toxicity: new insights into an old problem Clin Sci (Lond) Author manuscript; available in PMC 2012 Feb 1. Published in final edited form as: Clin Sci (Lond). 2011 Feb; 120(3):91-7.
Razzaque MS. The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis. Nature Rev Endocrinol. 2009;5(11):611.
Fifi K, de Rancher MA, Carteret CE, Maquart FX, Oudart JB. Unexpected Case of Bright Pink–Colored Plasma. Clin Chem. 2016;62(8):1162-3.
McCarron MM, Gaddis GP, Trotter AT. Acute yellow phosphorus poisoning from pesticide pastes. Clin Toxicol. 1981;18(6):693-711.
Mohideen S, Kumar K. Should ratol paste be banned?. Ind J Critic Care Med. 2015;19(2):128.
Shakoori V, Agahi M, Vasheghani-Farahani M, Marashi SM. Successful management of zinc phosphide poisoning. Ind J Crit Care Med Peer Rev Off Pub Ind Soc Crit Care Med. 2016;20(6):368.
Sikorska H1, Cianciara J, Wiercińska-Drapało A. Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency. Pol Merkur Lekarski. 2010;28(168):490-5.
Dooley JS, Sherlock's diseases of the Liver and Billiary system publishers John Wiley and sons; 13th Ed. 2018: 111-126.
Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, et al. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apheres.2006;21(2):96-9.
